Systemic Anti-Cancer Therapy Regimen Library
Neuroendocrine Regimens
Adrenocortical carcinoma Regimens
No regimens currently in this group
Neuroendocrine carcinoma Regimens
Published
Name
|
Version
|
Date
|
|---|---|---|
| Neuroendocrine carcinoma - cISplatin and etoposide 60/120 chemoradiation | 1.0.0 | 18/09/2023 |
| Neuroendocrine carcinoma - cISplatin and etoposide 80/100 chemoradiation | 1.0.0 | 18/09/2023 |
| Neuroendocrine carcinoma Advanced - cARBOplatin and etoposide | 1.0.0 | 11/09/2023 |
| Neuroendocrine carcinoma Advanced - cARBOplatin and oral etoposide | 1.0.0 | 11/09/2023 |
| Neuroendocrine carcinoma Advanced - CETUximab [Q2W] and encorafenib | 1.0.0 | 21/04/2025 |
| Neuroendocrine carcinoma Advanced - mFOLFIRI [irinotecan, foliNIc acid and fluorouracil] [high dose foliNIc acid] | 1.0.0 | 21/09/2023 |
Neuroendocrine neoplasm Regimens
Published
Neuroendocrine tumour Regimens
Published
|
Name
|
Version
|
Date
|
|---|---|---|
| Neuroendocrine tumour Advanced - capecitabine and temozolomide [ONCE daily dosing] | 1.0.0 | 08/05/2025 |
| Neuroendocrine tumour Advanced - everolimus | 1.0.0 | 11/09/2023 |
| Neuroendocrine tumour Advanced - lanreotide | 1.0.0 | 28/04/2025 |
| Neuroendocrine tumour PANC Advanced - sUNITinib | 1.0.0 | 11/09/2023 |